Advertisement

Metabolic Brain Disease

, Volume 31, Issue 5, pp 1047–1054 | Cite as

The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas

  • Gehan Ahmed MostafaEmail author
  • Geir Bjørklund
  • Mauricio A. Urbina
  • Laila Yousef Al-Ayadhi
Original Article

Abstract

The underlying pathogenic mechanism in autoimmune disorders is the formation of autoantibodies. In children with autism spectrum disorder (ASD), it has been documented increased levels of brain-specific autoantibodies. Furthermore, lead (Pb) has been identified as one of the main neurotoxicants acting as environmental triggers for ASD as it induces neuroinflammation and autoimmunity. The present study is the first to explore a potential relationship between the levels of blood lead (BPb) and seropositivity of anti-ribosomal P protein antibodies in ASD children. Levels of BPb and serum anti-ribosomal P protein antibodies were measured in 60 children with ASD and 60 healthy control matched children, aged between 5 and 12 years, recruited from low Pb-polluted areas. The levels of BPb were significantly higher in ASD children than in healthy control children (P < 0.001). Patients with ASD had significantly higher frequency of increased BPb levels 10 μg/dL (43.3 %) than healthy control children (13.3 %; P < 0.001). There were significant and positive correlations between the levels of BPb, and the values of Childhood Autism Rating Scale (CARS) (P < 0.01) and IQ in children with ASD (P < 0.001). Patients with ASD showing increased levels of BPb had significantly higher frequency of seropositivity of anti-ribosomal P antibodies (92.3 %) than patients with normal BPb levels (32.3 %; P < 0.001). The findings of the present study suggest that increased levels of BPb in some children with ASD may trigger the production of serum anti-ribosomal P antibodies. Further research is warranted to determine if the production of brain autoantibodies is triggered by environmental Pb exposure in children with ASD. The possible therapeutic role of Pb chelators in ASD children should also be studied.

Keywords

Anti-ribosomal P protein antibodies Autism Autoimmunity Blood lead Cognitive function 

Notes

Acknowledgments

This research project was supported by a grant from the Research Center of the Center for Female Scientific and Medical Colleges, Deanship of Scientific Research, King Saud University.

Compliance with ethical standards

Conflict of interest

The authors declare no potential conflicts of interest with respect to the authorship, and/or publication of this article.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. AAP - American Academy of Pediatrics Committee on Environmental Health (2005) Lead exposure in children: prevention, detection, and management. Pediatrics 116:1036–1046CrossRefGoogle Scholar
  2. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2013) Toxicological status of children with autism vs. neurotypical children and the association with autism severity. Biol Trace Elem Res 151:171–180CrossRefPubMedGoogle Scholar
  3. Alabdali A, Al-Ayadhi L, El-Ansary A (2014) A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders. Behav Brain Funct 10:14. doi: 10.1186/1744-9081-10-14 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Al-Ayadhi LY, Mostafa GA (2012) A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children. J Neuroinflammation 9:54. doi: 10.1186/1742-2094-9-54 PubMedPubMedCentralGoogle Scholar
  5. APA - American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, WashingtonGoogle Scholar
  6. Ben-Ami SD, Blank M, Altman A (2010) The clinical importance of anti-ribosomal-P antibodies (in Hebrew). Harefuah 149(794–797):810Google Scholar
  7. Blaurock-Busch E, Amin OR, Rabah T (2011) Heavy metals and trace elements in hair and urine of a sample of Arab children with autistic spectrum disorder. Maedica (Buchar) 6:247–257Google Scholar
  8. Blaurock-Busch E, Amin OR, Dessoki HH, Rabah T (2012a) Toxic metals and essential elements in hair and severity of symptoms among children with autism. Maedica (Buchar) 7:38–48Google Scholar
  9. Blaurock-Busch E, Amin OR, Dessoki HH, Rabah T (2012b) Efficacy of DMSA therapy in a sample of Arab children with autistic spectrum disorder. Maedica (Buchar) 7:214–221Google Scholar
  10. Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP (2003) Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348:1517–1526CrossRefPubMedPubMedCentralGoogle Scholar
  11. Caylak E, Aytekin M, Halifeoglu I (2008) Antioxidant effects of methionine, alpha-lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats. Exp Toxicol Pathol 60:289–294CrossRefPubMedGoogle Scholar
  12. CDC - Centers for Disease Control and Prevention (2012a) CDC response to advisory committee on childhood lead poisoning prevention: recommendations in “low level lead exposure harms children: a renewed call of primary prevention”. Centers for Disease Control and Prevention. http://www.cdc.gov/nceh/lead/acclpp/cdc_response_lead_exposure_recs.pdf. Accessed 7 March 2016
  13. CDC - Centers for Disease Control and Prevention (2012b) Blood lead levels in children: What do parents need to know to protect their children? Centers for Disease Control and Prevention. http://www.cdc.gov/nceh/lead/acclpp/lead_levels_in_children_fact_sheet.pdf. Accessed 7 March 2016
  14. CDC - Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention (2007) Interpreting and managing blood lead levels <10 microg/dL in children and reducing childhood exposures to lead: recommendations of CDC’s Advisory Committee on Childhood Lead Poisoning Prevention. MMWR Recomm Rep 56(RR-8):1–16Google Scholar
  15. Cohly HH, Panja A (2005) Immunological findings in autism. Int Rev Neurobiol 71:317–341CrossRefPubMedGoogle Scholar
  16. Fido A, Al-Saad S (2005) Toxic trace elements in the hair of children with autism. Autism 9:290–298CrossRefPubMedGoogle Scholar
  17. Gerli R, Caponi L (2005) Anti-ribosomal P protein antibodies. Autoimmunity 38:85–92CrossRefPubMedGoogle Scholar
  18. Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH (2002) Auto-antibodies in neuropsychiatric lupus. Autoimmunity 35:79–86CrossRefPubMedGoogle Scholar
  19. Ha M, Kwon HJ, Lim MH, Jee YK, Hong YC, Leem JH, Sakong J, Bae JM, Hong SJ, Roh YM, Jo SJ (2009) Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children’s health and environment research (CHEER). Neurotoxicology 30:31–36CrossRefPubMedGoogle Scholar
  20. Kamel NM, Ramadan AM, Kamel MI, Mostafa YA, Abo el-Naga RM, Ali AM (2003) Impact of lead exposure on health status and scholastic achievement of school pupils in Alexandria. J Egypt Public Health Assoc 78:1–28PubMedGoogle Scholar
  21. Kern JK, Grannemann BD, Trivedi MH, Adams JB (2007) Sulfhydryl-reactive metals in autism. J Toxicol Environ Health A 70:715–721CrossRefPubMedGoogle Scholar
  22. Kordas K, Casavantes KM, Mendoza C, Lopez P, Ronquillo D, Rosado JL, Vargas GG, Stoltzfus RJ (2007) The association between lead and micronutrient status, and children’s sleep, classroom behavior, and activity. Arch Environ Occup Health 62:105–112CrossRefPubMedGoogle Scholar
  23. Lakshmi Priya M, Geetha A (2010) Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol Trace Elem Res 142:148–158CrossRefPubMedGoogle Scholar
  24. Markowitz M (2000) Lead poisoning. Pediatr Rev 21:327–335CrossRefPubMedGoogle Scholar
  25. Matte TD (2003) Effects of lead exposure on children’s health (in Spanish). Salud Publica Mex 45(Suppl 2):S220–S224PubMedGoogle Scholar
  26. Meleka LK, Ismail ME (1999) Arabic translation of Wechsler intelligence scale for children, 6th edn. Egyptian Anglo library, CairoGoogle Scholar
  27. Mostafa GA, Al-Ayadhi LY (2011) The possible link between the elevated serum levels of neurokinin a and anti-ribosomal P protein antibodies in children with autism. J Neuroinflammation 8:180. doi: 10.1186/1742-2094-8-180 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Mostafa GA, El-Sayed ZA, Abd El Aziz MM, El-Sayed MF (2008) Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol 23:1413–1418CrossRefPubMedGoogle Scholar
  29. Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM (2010) Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol 219:114–118CrossRefPubMedGoogle Scholar
  30. Petranovic D, Batinac T, Petranovic D, Ruzic A, Ruzic T (2008) Iron deficiency anaemia influences cognitive functions. Med Hypotheses 70:70–72CrossRefPubMedGoogle Scholar
  31. Piomelli S (2002) Childhood lead poisoning. Pediatr Clin N Am 49:1285–1304CrossRefGoogle Scholar
  32. Quig D (1998) Cysteine metabolism and metal toxicity. Altern Med Rev 3:262–270PubMedGoogle Scholar
  33. Schopler E, Reichler RJ, Renner BR (1986) The childhood autism rating scale (CARS) for diagnostic screening and classification in autism. Irvington, New YorkGoogle Scholar
  34. Singh VK, Hanson J (2006) Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal. Pediatr Allergy Immunol 17:291–296CrossRefPubMedGoogle Scholar
  35. Singh VK, Rivas WH (2004) Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett 355:53–56CrossRefPubMedGoogle Scholar
  36. Singh VK, Lin SX, Yang VC (1998) Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 89:105–108CrossRefPubMedGoogle Scholar
  37. Tian Y, Green PG, Stamova B, Hertz-Picciotto I, Pessah IN, Hansen R, Yang X, Gregg JP, Ashwood P, Jickling G, Van de Water J, Sharp FR (2011) Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res 19:1–13CrossRefPubMedGoogle Scholar
  38. Toubi E, Shoenfeld Y (2007) Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 6:119–125CrossRefPubMedGoogle Scholar
  39. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E (2002) Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins form milk, chlamydia pneumoniae and streptococcus group a. J Neuroimmunol 129:168–177CrossRefPubMedGoogle Scholar
  40. Vojdani A, Pangborn JB, Vojdani E, Cooper EL (2003) Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major investigators of autoimmunity in autism. Int J Immunopathol Pharmacol 16:189–199PubMedGoogle Scholar
  41. Wechsler D (1991) Examiner’s manual: Wechsler intelligence scale for children, 3rd edn. Psychological Corporation, New YorkGoogle Scholar
  42. Yorbik O, Kurt I, Hasimi A, Ozturk O (2010) Chromium, cadmium, and lead levels in urine of children with autism and typically developing controls. Biol Trace Elem Res 135:10–15CrossRefPubMedGoogle Scholar
  43. Zheng W, Aschner M, Ghersi-Egea JF (2003) Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol 192:1–11CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Gehan Ahmed Mostafa
    • 1
    • 2
    Email author
  • Geir Bjørklund
    • 3
  • Mauricio A. Urbina
    • 4
  • Laila Yousef Al-Ayadhi
    • 2
  1. 1.Department of Pediatrics, Faculty of MedicineAin Shams UniversityCairoEgypt
  2. 2.Department of Physiology, Autism Research and Treatment Center, AL-Amodi Autism Research Chair, Faculty of MedicineKing Saud UniversityRiyadhSaudi Arabia
  3. 3.Council for Nutritional and Environmental MedicineMo i RanaNorway
  4. 4.Departamento de Zoología, Facultad de Ciencias Naturales y OceanográficasUniversidad de ConcepciónConcepciónChile

Personalised recommendations